Tvardi Therapeutics, Inc.
General ticker "TVRD" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $26.4M (TTM average)
Tvardi Therapeutics, Inc. does not follow the US Stock Market performance with the rate: -32.1%.
Estimated limits based on current volatility of 9.8%: low 0.99$, high 1.21$
Short-term TVRD quotes
Long-term TVRD plot
Financial data
| YTD | 2024-12-31 | 2025-12-31 |
|---|---|---|
| Operating Revenue | $7.14MM | $0.00MM |
| Operating Expenses | $62.92MM | $26.75MM |
| Operating Income | $-55.78MM | $-26.75MM |
| Non-Operating Income | $-15.48MM | $8.53MM |
| Interest Expense | $8.47MM | $0.00MM |
| R&D Expense | $32.76MM | $18.01MM |
| Income(Loss) | $-71.27MM | $-18.21MM |
| Taxes | $-0.40MM | $0.00MM |
| Net Income(Loss)* | $-70.87MM | $-18.21MM |
| Stockholders Equity | $-4.59MM | $20.95MM |
| Inventory | $0.90MM | $0.00MM |
| Assets | $43.83MM | $32.07MM |
| Operating Cash Flow | $-60.92MM | $-23.50MM |
| Capital expenditure | $1.05MM | $0.00MM |
| Investing Cash Flow | $48.74MM | $-10.08MM |
| Financing Cash Flow | $-3.60MM | $22.70MM |
| Earnings Per Share** | $-46.60 | $-2.46 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.